Lonza Group AG against Sanofi — live side-by-side technical comparison.
Prices as of 2026-10-13T15:30:39+00:00 UTC · updates daily
LONN.SW leads 4 of the 5 windows we measure — over 1 month LONN.SW is +6.6% and SNY -8.5%; over year to date LONN.SW is +5.3% and SNY -19.3%.
| LONN.SW | SNY | |
|---|---|---|
| Price | $566.40 | $39.12 |
| 1 day | -1.3%lead | -1.6% |
| 5 days | -1.7% | -1.1%lead |
| 1 month | +6.6%lead | -8.5% |
| 6 months | +9.6%lead | -16.7% |
| Year to date | +5.3%lead | -19.3% |
| 52-week position | 78% of range | 0% of range |
| 52-week range | $454.60–$597.80 | $39.07–$52.68 |
| vs 50-day average | below $567.65 | below $42.82 |
| vs 200-day average | above $532.75 | below $44.76 |
| RSI (14) | 52 | 27 |
| Next earnings | 2026-01-28 | 2026-10-30 |
LONN.SW trades at $566.40, below its 50-day average of $567.65, and above the 200-day at $532.75. It sits at 78% of its 52-week range ($454.60–$597.80); 14-day RSI is 52, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $567.65 (0.2% away) and the first support below is $554.60 (2.1% down). On the checklist the page runs for every asset, 3 of 6 checks read bullish — the lean is bullish.
SNY trades at $39.12, below its 50-day average of $42.82, and below the 200-day at $44.76. It sits at 0% of its 52-week range ($39.07–$52.68); 14-day RSI is 27, in oversold territory; an average session moves it about 1.9%. For levels, the first level overhead is $40.00 (2.2% away) and the first support below is $35.00 (10.5% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.
LONN.SW is the more volatile of the two — an average session moves it 2.3% against 1.9% for SNY, so an identical position size carries roughly 1.2× the daily risk.
The comparison turns on those levels: LONN.SW clearing $567.65 or losing $554.60; SNY clearing $40.00 or losing $35.00. Until one of them gives way, the relative reading above stands.